TALPHERA, INC. (TLPH) Scorecard
- 2026-Q2: Total return Win; Revenue growth Lose; EPS growth Lose.
- 2026-Q1: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2025-Q4: Total return Win; Revenue growth Lose; EPS growth Lose.
- 2025-Q3: Total return Win; Revenue growth Lose; EPS growth Lose.
28/120
All 120 Win/Lose results shown below
Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
Trailing 1 year (4 quarters): 3 wins, 9 lossesLast fetched: 4 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q21/3 |
WinTLPH / S&P 37.33% / 15.20% |
LoseTLPH / S&P -96.30% / 15.00% |
LoseTLPH / S&P TLPH unavailable / 50.40% |
| 2026-Q10/3 |
LoseTLPH / S&P -34.21% / -4.33% |
LoseTLPH / S&P -96.30% / 11.30% |
LoseTLPH / S&P TLPH unavailable / 27.70% |
| 2025-Q41/3 |
WinTLPH / S&P 28.09% / 2.65% |
LoseTLPH / S&P TLPH unavailable / 9.00% |
LoseTLPH / S&P TLPH unavailable / 13.40% |
| 2025-Q31/3 |
WinTLPH / S&P 93.48% / 8.12% |
LoseTLPH / S&P -90.04% / 4.61% |
LoseTLPH / S&P TLPH unavailable / 13.45% |
| 2025-Q20/3 |
LoseTLPH / S&P -8.00% / 10.94% |
LoseTLPH / S&P -93.22% / 4.83% |
LoseTLPH / S&P TLPH unavailable / 10.63% |
| 2025-Q11/3 |
WinTLPH / S&P -3.85% / -4.27% |
LoseTLPH / S&P -95.85% / 4.98% |
LoseTLPH / S&P TLPH unavailable / 10.57% |
| 2024-Q40/3 |
LoseTLPH / S&P -39.53% / 2.41% |
LoseTLPH / S&P TLPH unavailable / 5.25% |
LoseTLPH / S&P TLPH unavailable / 6.15% |
| 2024-Q30/3 |
LoseTLPH / S&P -3.37% / 5.89% |
LoseTLPH / S&P TLPH unavailable / 5.89% |
LoseTLPH / S&P TLPH unavailable / 6.11% |
| 2024-Q20/3 |
LoseTLPH / S&P -13.59% / 4.28% |
LoseTLPH / S&P TLPH unavailable / 5.38% |
LoseTLPH / S&P TLPH unavailable / 5.12% |
| 2024-Q11/3 |
WinTLPH / S&P 39.19% / 10.56% |
LoseTLPH / S&P TLPH unavailable / 5.71% |
LoseTLPH / S&P TLPH unavailable / 5.59% |
| 2023-Q41/3 |
WinTLPH / S&P 27.59% / 11.69% |
LoseTLPH / S&P TLPH unavailable / 6.81% |
LoseTLPH / S&P TLPH unavailable / 7.78% |
| 2023-Q30/3 |
LoseTLPH / S&P -47.75% / -3.27% |
LoseTLPH / S&P TLPH unavailable / 7.52% |
LoseTLPH / S&P TLPH unavailable / -5.03% |
| 2023-Q21/3 |
WinTLPH / S&P 68.18% / 8.74% |
LoseTLPH / S&P TLPH unavailable / 9.50% |
LoseTLPH / S&P TLPH unavailable / -8.57% |
| 2023-Q10/3 |
LoseTLPH / S&P -70.80% / 7.50% |
LoseTLPH / S&P TLPH unavailable / 10.77% |
LoseTLPH / S&P TLPH unavailable / -15.69% |
| 2022-Q40/3 |
LoseTLPH / S&P -46.19% / 7.56% |
LoseTLPH / S&P -84.32% / 11.88% |
LoseTLPH / S&P TLPH unavailable / -17.99% |
| 2022-Q30/3 |
LoseTLPH / S&P -12.50% / -4.88% |
LoseTLPH / S&P -87.51% / 13.47% |
LoseTLPH / S&P TLPH unavailable / -1.41% |
| 2022-Q20/3 |
LoseTLPH / S&P -17.24% / -16.10% |
LoseTLPH / S&P -24.64% / 13.71% |
LoseTLPH / S&P TLPH unavailable / 11.04% |
| 2022-Q10/3 |
LoseTLPH / S&P -48.21% / -4.60% |
LoseTLPH / S&P -50.39% / 15.97% |
LoseTLPH / S&P TLPH unavailable / 42.23% |
| 2021-Q40/3 |
LoseTLPH / S&P -45.10% / 11.03% |
LoseTLPH / S&P -47.97% / 15.00% |
LoseTLPH / S&P TLPH unavailable / 96.40% |
| 2021-Q30/3 |
LoseTLPH / S&P -26.09% / 0.58% |
LoseTLPH / S&P -31.03% / 10.77% |
LoseTLPH / S&P TLPH unavailable / 69.42% |
| 2021-Q20/3 |
LoseTLPH / S&P -18.82% / 8.55% |
LoseTLPH / S&P -30.34% / 6.58% |
LoseTLPH / S&P TLPH unavailable / 51.81% |
| 2021-Q12/3 |
WinTLPH / S&P 37.10% / 6.17% |
WinTLPH / S&P 129.92% / -1.06% |
LoseTLPH / S&P TLPH unavailable / 7.39% |
| 2020-Q41/3 |
LoseTLPH / S&P -12.68% / 12.15% |
WinTLPH / S&P 136.61% / -3.72% |
LoseTLPH / S&P TLPH unavailable / -33.42% |
| 2020-Q32/3 |
WinTLPH / S&P 17.36% / 8.93% |
WinTLPH / S&P 112.32% / -2.04% |
LoseTLPH / S&P TLPH unavailable / -27.10% |
| 2020-Q21/3 |
LoseTLPH / S&P 2.54% / 20.54% |
WinTLPH / S&P 100.05% / -0.46% |
LoseTLPH / S&P TLPH unavailable / -27.11% |
| 2020-Q11/3 |
LoseTLPH / S&P -44.08% / -19.60% |
WinTLPH / S&P 16.26% / 3.47% |
LoseTLPH / S&P TLPH unavailable / -14.75% |
| 2019-Q41/3 |
LoseTLPH / S&P -4.09% / 9.07% |
WinTLPH / S&P 6.42% / 5.36% |
LoseTLPH / S&P TLPH unavailable / 2.99% |
| 2019-Q31/3 |
LoseTLPH / S&P -13.04% / 1.70% |
WinTLPH / S&P 6.54% / 5.02% |
LoseTLPH / S&P TLPH unavailable / 0.21% |
| 2019-Q20/3 |
LoseTLPH / S&P -27.30% / 4.30% |
LoseTLPH / S&P -35.18% / 6.64% |
LoseTLPH / S&P TLPH unavailable / 8.65% |
| 2019-Q11/3 |
WinTLPH / S&P 50.65% / 13.65% |
LoseTLPH / S&P -60.36% / 8.12% |
LoseTLPH / S&P TLPH unavailable / 14.29% |
| 2018-Q40/3 |
LoseTLPH / S&P -40.00% / -13.52% |
LoseTLPH / S&P -73.10% / 9.05% |
LoseTLPH / S&P TLPH unavailable / 18.23% |
| 2018-Q31/3 |
WinTLPH / S&P 13.91% / 7.71% |
LoseTLPH / S&P -83.36% / 10.21% |
LoseTLPH / S&P TLPH unavailable / 19.06% |
| 2018-Q21/3 |
WinTLPH / S&P 60.95% / 3.43% |
LoseTLPH / S&P -78.24% / 9.03% |
LoseTLPH / S&P TLPH unavailable / 14.46% |
| 2018-Q11/3 |
WinTLPH / S&P 3.45% / -0.76% |
LoseTLPH / S&P -70.02% / 7.68% |
LoseTLPH / S&P TLPH unavailable / 12.46% |
| 2017-Q40/3 |
LoseTLPH / S&P -55.87% / 6.64% |
LoseTLPH / S&P -53.94% / 7.03% |
LoseTLPH / S&P TLPH unavailable / 13.82% |
| 2017-Q32/3 |
WinTLPH / S&P 113.95% / 4.48% |
WinTLPH / S&P 8.20% / 5.68% |
LoseTLPH / S&P TLPH unavailable / 17.57% |
| 2017-Q21/3 |
LoseTLPH / S&P -31.75% / 3.09% |
LoseTLPH / S&P -37.00% / 4.83% |
WinTLPH / S&P 78.69% / 17.74% |
| 2017-Q12/3 |
WinTLPH / S&P 21.15% / 6.07% |
LoseTLPH / S&P -21.11% / 3.67% |
WinTLPH / S&P 82.46% / 13.32% |
| 2016-Q41/3 |
LoseTLPH / S&P -33.16% / 3.82% |
LoseTLPH / S&P -9.89% / 2.09% |
WinTLPH / S&P 61.02% / 7.05% |
| 2016-Q32/3 |
WinTLPH / S&P 44.61% / 3.85% |
LoseTLPH / S&P -28.76% / 0.20% |
WinTLPH / S&P 51.56% / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-27
| Metric | TLPH total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 127.78% | 20.78% |
| Annualized return | 127.78% | 20.78% |
5Y · 2021-09-01 to 2026-08-27
| Metric | TLPH total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -94.36% | 83.14% |
| Annualized return | -43.73% | 12.86% |
10Y · 2016-09-01 to 2026-08-27
| Metric | TLPH total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -97.98% | 319.30% |
| Annualized return | -32.32% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-04.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |